StreetInsider.com News Articles

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

SYDNEY, June 24, 2026 (GLOBE NEWSWIRE) -- AI and Medical Technology Company Echo IQ Limited (ASX: EIQ) ("Echo IQ" or "the Company") today announced two key appointments to its executive leadership team and broader clinical advisory network to support the next phase

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Wed, 24 Jun 2026 08:00:00 -0400

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience
Dr. Vinod Thourani appointed Clinical Advisor, adding one of the world's leading structural heart and valve disease specialists to Echo IQ's growing network of key opinion leaders